Haemonetics (HAE) Total Current Liabilities (2010 - 2026)

Haemonetics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $282.6 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 51.12% year-over-year to $282.6 million in Q1 2026; TTM through Mar 2026 was $282.6 million, a 51.12% decrease from a year earlier, with the FY2026 full-year figure at $282.6 million, down 51.12% from the prior year.
• Total Current Liabilities retreated to $282.6 million in Q1 2026 per HAE's latest filing, from $539.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $578.1 million in Q1 2025 and bottomed at $180.5 million in Q3 2022.
• The 5-year median for Total Current Liabilities is $269.1 million (2023), against an average of $336.1 million.
• Across the five-year window, Total Current Liabilities soared 113.19% in 2025 and sank 51.12% in 2026, its largest moves.
• Year by year, Total Current Liabilities stood at $226.9 million in 2022, then rose by 15.37% to $261.8 million in 2023, then decreased by 3.26% to $253.2 million in 2024, then surged by 113.19% to $539.9 million in 2025, then tumbled by 47.65% to $282.6 million in 2026.
• Per Business Quant, the three latest HAE Total Current Liabilities figures stand at $282.6 million (Q1 2026), $539.9 million (Q4 2025), and $548.3 million (Q3 2025).